Treatment for Bladder Stones
Transurethral cystolithotripsy (TUCL) is the recommended first-line treatment for bladder stones in adults and children where feasible. 1
Diagnostic Approach
Before initiating treatment, proper diagnosis is essential:
Imaging studies:
Laboratory evaluation:
Treatment Options
Treatment selection depends on stone size, composition, and patient factors:
1. Endoscopic Procedures
Transurethral cystolithotripsy (TUCL):
Percutaneous cystolithotripsy (PCCL):
- Alternative to TUCL for larger stones
- Similar stone-free rates to TUCL but longer hospital stay (mean difference 0.82 days) and procedure duration (mean difference 9.83 minutes) 1
2. Shock Wave Lithotripsy (SWL)
- Less effective than TUCL with lower stone-free rates 1
- Generally not recommended as first-line therapy for bladder stones
3. Open Cystolithotomy
- Reserved for very large stones or when endoscopic approaches are not feasible
- Similar stone-free rates to endoscopic procedures but longer hospital stay and recovery time 1
- Tubeless cystolithotomy may offer shorter hospital stays in selected cases 1
4. Medical Management
- Medical expulsive therapy (alpha-blockers) can increase stone passage rates by 29% compared to control treatments 3
- Oral chemolysis is strongly recommended for uric acid stones, with 80.5% success rate 3
Special Considerations
Infection and Obstruction Management
- In cases of sepsis and/or anuria with obstruction:
Underlying Conditions
Bladder stones often occur secondary to:
High concordance (70%) between bladder stone and kidney stone composition suggests metabolic factors play a significant role 5
Follow-up and Prevention
- Follow-up imaging (KUB X-ray or ultrasound) within 1-2 weeks of treatment 3
- Increase fluid intake to more than 2L/day to prevent recurrence 3
- Metabolic evaluation should be considered to prevent recurrence 3
- Evaluation for predisposing factors including congenital abnormalities, neurogenic bladder, metabolic disorders, and recurrent UTIs 3
Common Pitfalls
- Failing to address underlying causes (e.g., bladder outlet obstruction, metabolic abnormalities) may lead to stone recurrence
- Delaying treatment in cases of infection with obstruction can lead to urosepsis and increased morbidity
- Underestimating the role of metabolic factors in bladder stone formation may result in inadequate prevention strategies
- Not considering stone composition when selecting treatment approach (e.g., oral chemolysis for uric acid stones)